In the week of August 31, 2026, 20 holders filed a new Schedule 13D and 71 a new Schedule 13G reporting 5% or more of a company. The largest stake reported that week is Pure Raw Supplies, LLC's 100% of Nutra Pharma Corp (Schedule 13D, September 1, 2026).
New 13D20
New 13G71
Stated intents0
The week of 2026-08-31, 20 holders filed a new Schedule 13D and 71 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-09-01 | Nutra Pharma Corp | Pure Raw Supplies, LLC | 100% | SCHEDULE 13D |
| 2026-09-04 | Bioforce Nanosciences Holdings, Inc. | Nexus Capital Investments, Inc. | 79.6% | SCHEDULE 13D |
| 2026-08-31 | Etoiles Capital Group Co., Ltd | Etoiles Zeneo Investment Ltd | 68.08% | SCHEDULE 13D |
| 2026-09-02 | Definitive Healthcare Corp | Advent International, L.P. | 58.54% | SCHEDULE 13D |
| 2026-08-31 | LeonaBio, Inc. | Sermonix Pharmaceuticals, Inc. | 36.9% | SCHEDULE 13D |
| 2026-09-04 | AMG Pantheon Infrastructure Fund, LLC | BlueArc Capital Management, LLC | 32.3% | SCHEDULE 13D |
| 2026-08-31 | Southern Cross Acquisition II Corp. | Southern Cross Acquisition II Sponsor Corp. | 27.75% | SCHEDULE 13D |
| 2026-08-31 | Starfighters Space, Inc. | Richard William Svetkoff | 23.85% | SCHEDULE 13D |
| 2026-09-03 | JATT III Acquisition Corp | JATT Ventures III L.P. | 22.1% | SCHEDULE 13D |
| 2026-09-02 | AMG Pantheon Infrastructure Fund, LLC | BlueArc Capital Management, LLC | 21.3% | SCHEDULE 13D |
| 2026-09-04 | Radiopharm Theranostics Limited | Lantheus Holdings, Inc. | 20.9% | SCHEDULE 13D |
| 2026-09-02 | AMG Pantheon Infrastructure Fund, LLC | BlueArc Capital Management, LLC | 20.4% | SCHEDULE 13D |
| 2026-09-03 | Dynaresource, Inc. | Nichol Gareth | 20.17% | SCHEDULE 13D |
| 2026-09-02 | Definitive Healthcare Corp | Jason Ronald Krantz | 17.6% | SCHEDULE 13D |
| 2026-09-03 | Pasqal Holding SA | Bpifrance Participations S.A. | 11.4% | SCHEDULE 13D |
| 2026-09-03 | SkyAI, Inc. | Bastion Trading Limited | 9.9% | SCHEDULE 13D |
| 2026-09-03 | KLX Energy Services Holdings, Inc. | Steel Partners Holdings L.P. | 8.9% | SCHEDULE 13D |
| 2026-09-04 | VolitionRx Limited | Lagoda Investment Management, L.P. | 7.4% | SCHEDULE 13D |
| 2026-09-03 | Nexalin Technology, Inc. | Greenlight Ventures, LLC | 5.6% | SCHEDULE 13D |
| 2026-09-02 | Dynatrace, Inc. | Pictet Asset Management Sa | 5% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-09-03 | Dimensional ETF Trust | First Command Advisory Services, Inc. | 37.8% | SCHEDULE 13G |
| 2026-09-02 | Innovator ETFs Trust | Brookstone Capital Management, LLC | 23.15% | SCHEDULE 13G |
| 2026-09-02 | Calamos Global Dynamic Income Fund | Thrivent Financial For Lutherans | 22.8% | SCHEDULE 13G |
| 2026-09-02 | Calamos Dynamic Convertible & Income Fund | Thrivent Financial For Lutherans | 21.4% | SCHEDULE 13G |
| 2026-09-02 | AMG Pantheon Infrastructure Fund, LLC | BlueArc Capital Management, LLC | 19.2% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | Origin Force Intelligence Limited | 18.3% | SCHEDULE 13G |
| 2026-09-01 | Freenome, Inc. | Roche Holdings, Inc. | 17.4% | SCHEDULE 13G |
| 2026-09-04 | Radiopharm Theranostics Limited | Lantheus Omega, LLC | 17.3% | SCHEDULE 13G |
| 2026-09-02 | Bluemount Holdings Ltd | Siu Hiu Ki Jamie | 16.2% | SCHEDULE 13G |
| 2026-09-02 | AMG Pantheon Infrastructure Fund, LLC | BlueArc Capital Management, LLC | 14.3% | SCHEDULE 13G |
| 2026-09-04 | Adi Global Distribution Inc | BlackRock, Inc. | 13.5% | SCHEDULE 13G |
| 2026-09-02 | AMG Pantheon Infrastructure Fund, LLC | BlueArc Capital Management, LLC | 12.2% | SCHEDULE 13G |
| 2026-09-03 | Rainier Acquisition Corporation | 683 Capital Management, LLC | 11.2% | SCHEDULE 13G |
| 2026-09-03 | Rainier Acquisition Corporation | 683 Capital Management, LLC | 11.2% | SCHEDULE 13G |
| 2026-09-04 | Tcw Specialty Lending LLC | First Trust Capital Management L.P. | 11.19% | SCHEDULE 13G |
| 2026-09-04 | Myriad Genetics Inc | BlackRock Portfolio Management LLC | 10.4% | SCHEDULE 13G |
| 2026-09-04 | iShares S&P GSCI Commodity-Indexed Trust | BlackRock Portfolio Management LLC | 10.4% | SCHEDULE 13G |
| 2026-09-02 | Mint Incorporation Limited | L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% | SCHEDULE 13G |
| 2026-09-02 | Glucotrack, Inc. | White Lion Capital LLC | 9.99% | SCHEDULE 13G |
| 2026-09-04 | Conexeu Sciences Inc. | Multi-Valor AIF Umbrella Fund SICAV Quintus Growth Fund | 9.99% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | Orbis BioCapital Limited | 9.98% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | Whitmore Limited | 9.97% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | Horizon Ridge Limited | 9.97% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | Clever Way Global Limited | 9.96% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | Meridian Prosperous Limited | 9.96% | SCHEDULE 13G |
| 2026-08-31 | Royalty Management Holding Corp | Liberty Hill Capital Management, LLC | 9.95% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | Star Voyage International Limited | 9.94% | SCHEDULE 13G |
| 2026-09-02 | CDT Equity Inc. | Taylor Mark Andrew | 9.6% | SCHEDULE 13G |
| 2026-09-01 | Universe Pharmaceuticals INC | August Luck Global Limited | 9.29% | SCHEDULE 13G |
| 2026-09-03 | C3is Inc. | Horne Timothy P | 9.1% | SCHEDULE 13G |
| 2026-09-03 | Avantis US Large Cap Value ETF | First Command Advisory Services, Inc. | 8.4% | SCHEDULE 13G |
| 2026-09-02 | Greenland Mines Ltd | Davidson Kempner Capital Management LP | 8.32% | SCHEDULE 13G |
| 2026-09-02 | ZeroStack Corp. | Puple AI Inc. | 8.3% | SCHEDULE 13G |
| 2026-09-04 | ZeroStack Corp. | Blockcat Pte. Ltd. | 8.3% | SCHEDULE 13G |
| 2026-09-04 | Arbutus Biopharma Corp | Whitefort Capital Master Fund, LP | 8% | SCHEDULE 13G |
| 2026-09-03 | Invesco Exchange-Traded Self-Indexed Fund Trust | First Command Advisory Services, Inc. | 7.8% | SCHEDULE 13G |
| 2026-09-04 | New Century Logistics (BVI) Ltd | Chen Xueyi | 7.78% | SCHEDULE 13G |
| 2026-09-03 | Pediatrix Medical Group, Inc. | Vanguard Portfolio Management | 7.55% | SCHEDULE 13G |
| 2026-09-03 | Zions Bancorporation, National Association | Vanguard Portfolio Management | 7.4% | SCHEDULE 13G |
| 2026-09-02 | Turtle Beach Corporation | 22NW Fund, LP | 7.29% | SCHEDULE 13G |
| 2026-08-31 | Femasys Inc. | Stonepine Capital Management, LLC | 7.2% | SCHEDULE 13G |
| 2026-09-03 | Royalty Management Holding Corp | Midwest General Investment Co LLC | 7% | SCHEDULE 13G |
| 2026-09-04 | Pasqal Holding SA | Inflection Point Fund I, LP | 7% | SCHEDULE 13G |
| 2026-09-03 | Spdr Index Shares Funds | First Command Advisory Services, Inc. | 6.9% | SCHEDULE 13G |
| 2026-09-02 | TAT Technologies Ltd | Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD | 6.25% | SCHEDULE 13G |
| 2026-09-01 | Rush Street Interactive Inc | Divisadero Street Capital Management, LP | 6.2% | SCHEDULE 13G |
| 2026-09-02 | JATT III Acquisition Corp | Deep Track Capital, LP | 5.83% | SCHEDULE 13G |
| 2026-09-02 | JATT III Acquisition Corp | Great Point Partners, LLC | 5.83% | SCHEDULE 13G |
| 2026-09-03 | Cal-Maine Foods Inc | Vanguard Portfolio Management | 5.75% | SCHEDULE 13G |
| 2026-09-04 | Karyopharm Therapeutics Inc. | Integrated Core Strategies (US) LLC | 5.7% | SCHEDULE 13G |
| 2026-09-02 | Bitgo Holdings, Inc. | Nydig Ihc LLC | 5.46% | SCHEDULE 13G |
| 2026-08-31 | Katapult Holdings, Inc. | Advantage Insurance Inc. | 5.4% | SCHEDULE 13G |
| 2026-09-03 | Liberty Media Corp | Vanguard Capital Management | 5.35% | SCHEDULE 13G |
| 2026-08-31 | Evolus, Inc | Soleus Capital Master Fund, L.P. | 5.3% | SCHEDULE 13G |
| 2026-09-01 | Fortress Biotech, Inc. | Integrated Core Strategies (US) LLC | 5.3% | SCHEDULE 13G |
| 2026-09-03 | iShares Managed Futures Active ETF | First Command Advisory Services, Inc. | 5.3% | SCHEDULE 13G |
| 2026-09-03 | Zions Bancorporation, National Association | Vanguard Capital Management | 5.25% | SCHEDULE 13G |
| 2026-09-03 | FTAI Aviation Ltd. | Vanguard Capital Management | 5.22% | SCHEDULE 13G |
| 2026-09-03 | Molina Healthcare Inc | Giovanni Agnelli B.V. | 5.21% | SCHEDULE 13G |
| 2026-09-01 | Rainier Acquisition Corporation | MMCAP International Inc. SPC | 5.2% | SCHEDULE 13G |
| 2026-09-02 | JATT III Acquisition Corp | Commodore Capital LP | 5.2% | SCHEDULE 13G |
| 2026-09-03 | Biovie Inc. | Jane Street Group, LLC | 5.2% | SCHEDULE 13G |
| 2026-09-03 | Bellring Brands, Inc. | Vanguard Capital Management | 5.2% | SCHEDULE 13G |
| 2026-09-04 | X-Energy, Inc. | Jane Street Group, LLC | 5.2% | SCHEDULE 13G |
| 2026-09-03 | Pediatrix Medical Group, Inc. | Vanguard Capital Management | 5.15% | SCHEDULE 13G |
| 2026-09-03 | Bellring Brands, Inc. | Vanguard Portfolio Management | 5.11% | SCHEDULE 13G |
| 2026-09-04 | Liberty Media Corp | Vanguard Capital Management | 5.11% | SCHEDULE 13G |
| 2026-09-01 | New ERA Energy & Digital, Inc. | Mccarthy Kent C | 5.1% | SCHEDULE 13G |
| 2026-09-03 | JATT III Acquisition Corp | RA Capital Management, L.P. | 5.1% | SCHEDULE 13G |
| 2026-09-04 | PG&E Corp | SteelMill Master Fund LP | 5.1% | SCHEDULE 13G |
| 2026-09-03 | XTI Aerospace, Inc. | Patrick Green Harrington | 5.08% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Download this data (CSV)91 rows, with sources. Free with an account.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.